HDAC1 and ovarian cancer: Among them, given that HDACis have been shown to induce DNA damage during DNA replication, leading to increased tumor neoantigen and active antitumor effects,[22] we established subcutaneous and intra‐peritoneal xenograft tumor model using HRP ovarian cancer cell line SKOV3, which has high expression level of HDAC1 (Figure S1H,I, Supporting Information) and evaluated its response to different treatment modalities.